Major Depressive Disorder

Patrick Astourian, MSPA-C, talked about differentiating between inflammatory and noninflammatory arthritis, understanding what diagnostic tests to order on the swollen joint, and when to refer your patient...

Larry Culpepper, MD, MPH, gave the audience an update on diagnosing, managing, and treating fibromyalgia during this afternoon’s session.

Joel J. Heidelbaugh, MD, spoke about evaluating and managing epigastric discomfort, recognizing “alarm” symptoms in patients, and understanding when to test for Helicobacter pylori infection.

Daniel Einhorn, MD, discussed the 2020-2021 guidelines for managing diabetes, including the new definition of prediabetes, patient-centered decision-making, and pharmacologic interventions.

Kathryn Kreider, DNP, discussed considerations for medication selection for type 2 diabetes, initiation of GLP-1 receptor agonists and SGLT-2 inhibitors, and the initiation of basal insulin for type 2...

Seth Martin, MD, MHS, spoke about the evolving role of telemedicine in the way that health care providers serve their patients, as well as barriers to telehealth treatment and ways to overcome them.

Jeffrey P. Levine, MD, MPH, spoke about identifying patients for osteoporosis and osteopenia therapy, monitoring osteoporosis treatment, and the appropriate duration of each treatment.

Michael Bloch, MD, spoke about pseudoresistance, secondary causes of hypertension, and creating a treatment strategy for your patients.

Michael Bloch, MD, spoke about pseudoresistance, secondary causes of hypertension, and creating a treatment strategy for your patients.

Michael Bloch, MD, spoke about pseudoresistance, secondary causes of hypertension, and creating a treatment strategy for your patients.